Skip to main content

Table 1 Comparison of baseline data, hematological parameters and coronary angiography data between elevated RBG group and control group

From: Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction

VariablesElevated RBG group (n = 265)Control group(n = 693)P value
Gender(man)193 (72.8%)551 (79.5%)0.026*
Age64.08 ± 12.9461.64 ± 13.470.019*
Height(cm)166.71 ± 7.44166.78 ± 7.540.92
Weight(kg)68.55 ± 12.1868.76 ± 11.380.844
BMI(kg/m2)24.93 ± 3.8724.44 ± 3.530.132
SBP(mmHg)124.80 ± 24.80126.52 ± 20.830.315
DBP(mmHg)76.14 ± 16.2976.98 ± 14.320.472
Hypertension167 (63.0%)384 (55.4%)0.033*
Diabetes174 (65.7%)88 (12.7%)< 0.001*
Previous MI12 (4.5%)10 (1.4%)0.013*
Cerebral infarction37 (14.0%)65 (9.4%)0.040*
CKD30 (11.3%)49 (7.1%)0.032*
Smoking119 (44.9%)380 (54.8%)0.006*
Killip grade
 I grade158 (59.6%)502 (72.4%)< 0.001*
 II grade42 (15.8%)112 (16.1%)0.906
 III grade2 (0.8%)9 (1.3%)0.480
 IV grade63 (23.8%)70 (10.1%)< 0.001*
TNI P50(P25-P75)(ng/ml)17.9 (3.2–25)14 (3.53–25)0.286
Myo P50(P25-P75) (ng/ml)500 (241–900)500 (239–900)0.096
CK-MB P50(P25-P75)(ng/ml)80 (26.9–292)80 (44–303.25)0.406
BNP P50(P25-P75) (pg/ml)216.5 (55.9–862)134 (43.3–393.25)0.002*
WBC (*10^9/L)12.46 ± 4.6111.19 ± 3.68< 0.001*
Hb (g/L)133.21 ± 23.15135.99 ± 20.710.098
PLT (*10^9/L)207.48 (146.4–289.3)204.68 (130.5–275.2)0.564
RBG(mmol/L)16.34 (13.2–20.6)7.35 (6.8–9.6)< 0.001*
ALT P50(P25-P75)IU/L)53 (34–82)44 (30–68.75)0.001*
AST P50(P25-P75) (IU/L)174.5 (79–323)157.5 (76.75–262.25)0.073
Scr P50(P25-P75) (μmol/L)81 (71–105.5)80.5 (69–92)0.1
eGFR P50(P25-P75)
(ml/min/1.73m2)
77.18 (54.95–96.24)82.37 (68.89–97.27)0.022*
UA(μmol/L)364.18 (318.3–468.6)366.75 (314.6–453.3)0.079
FBG(mmoL/L)12.00 ± 5.476.45 ± 2.02< 0.001*
TG(mmoL/L)2.12 (1.68–3.39)1.67 (1.32–2.87)0.004*
TC(mmoL/L)4.27 (3.03–5.97)4.48 (2.97–5.42)0.044*
HDL-c(mmoL/L)1.02 (0.82–1.88)1.13 (1.01–1.96)< 0.001*
LDL-c(mmoL/L)2.62 (2.38–3.42)2.80 (2.07–3.36)0.017*
LVEF (%)0.54 ± 0.120.58 ± 0.11< 0.0010*
Aspirin263 (99.2%)681 (98.3%)0.26
Clopidogrel21 (7.9%)95 (13.7%)0.014*
Ticagrelor244(%)598 (86.3%)0.014*
ACEI/ARB112 (92.1%)370 (53.4%)0.002*
β-blocker214 (80.8%)580 (83.7%)0.28
Statin265 (100%)688 (99.3%)0.166
CCB16 (6.0%)44 (6.3%)0.338
Furosemide72 (27.1%)177 (25.8%)0.424
Antisterone70 (26.4%)179(%)0.261
IABP28 (10.6%)35 (5.1%)0.002*
CABG5 (1.9%)8 (1.2%)0.381
Coronary lesions
 Single vessel lesion44 (16.6%)192 (27.7%)< 0.001*
 Double vessel lesions95 (35.8%)191 (27.6%)0.012*
 Triple vessel lesions126 (47.5%)310 (44.7%)0.434
Number of stents
 Single stent167 (63.0%)415 (59.9%)0.374
 Two or more stents44 (5.3%)133 (19.2%)0.356
 Left main lesion37 (14.0%)62 (9.0%)0.023*
  1. BMI Body Mass Index, SBP Systolic blood pressure, DBP Diastolic blood pressure, CKD Chronic kidney diseases, TNI Troponin, Myo Myohemoglobin, CK-MB Creatine Kinase-MB, BNP Brain natriuretic peptide, WBC White blood cell, Hb Hemoglobin, PLT Platelet, RBG Random blood glucose, ALT Alanine transaminase, AST Aspartate transaminase, Scr Serum creatinine, eGFR Estimated glomerular filtration rate, UA Uric Acid, FBG Fasting blood glucose, TG Triglyceride, TC Total cholesterol, HDL-c High density lipoprotein-cholesterol, LDL-c Low density lipoproten-cholesterol, LVEF Left ventricular ejection fraction, CCB Calcium channel blocker, IABP Intra-aortic ballon pump, CABG Coronary Artery Bypass Grafting